PCS | MCS | |||||||
Univariable model | Multivariable model | Univariable model | Multivariable model | |||||
B (SE) | P value | B (SE) | p value | B (SE) | P value | B (SE) | p value | |
Self-efficacy for managing daily activities | 1.59 (0.13) | <0.001 | 0.22 (0.13) | 0.091 | 1.44 (0.13) | <0.001 | 0.39 (0.13) | 0.002 |
Self-efficacy for managing symptoms | 1.26 (0.14) | <0.001 | 0.25 (0.11) | 0.021 | 1.19 (0.13) | <0.001 | 0.32 (0.12) | 0.006 |
Self-efficacy for managing medications and treatment* | 0.71 (0.17) | <0.001 | 0.20 (0.10) | 0.046 | 0.65 (0.16) | <0.001 | 0.24 (0.10) | 0.016 |
Self-efficacy for managing emotions | 0.99 (0.16) | <0.001 | 0.12 (0.11) | 0.257 | 1.05 (0.15) | <0.001 | 0.17 (0.11) | 0.161 |
Self-efficacy for managing social interactions | 0.77 (0.15) | <0.001 | 0.27 (0.09) | 0.002 | 0.86 (0.14) | <0.001 | 0.37 (0.10) | <0.001 |
General self-efficacy | 0.98 (0.11) | <0.001 | 0.18 (0.08) | 0.037 | 0.92 (0.11) | <0.001 | 0.20 (0.10) | 0.051 |
Adjusted for age at diagnosis, gender, socioeconomic status, SLEDAI-2K, SLICC/American College of Rheumatology Damage Index, disease duration at baseline, prednisone daily dose, antimalarial and immunosuppressive drugs use and the PCS or MCS in the previous visit.
Values in bold are those that are statistically significant.
*One patient was excluded as she was not taking any medication during her follow-up.
HRQoL, health-related quality of life; MCS, mental component summary; PCS, physical component summary; PROMIS, Patient-Reported Outcomes Measurement Information System; SLEDAI-2K, Systemic Lupus Erythematosus Disease Activity Index 2K; SLICC, Systemic Lupus International Collaborating Clinics.